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PCardiac Magnetic Resonance With Edema
Imaging Identifies Myocardium at Risk and
Predicts Worse Outcome in Patients With
Non–ST-Segment Elevation Acute Coronary Syndrome
Subha V. Raman, MD, MSEE,* Orlando P. Simonetti, PHD,* Marshall W. Winner III, MD,*
Jennifer A. Dickerson, MD,* Xin He, PHD,† Ernest L. Mazzaferri, JR, MD,*
Giuseppe Ambrosio, MD, PHD‡
Columbus, Ohio; College Park, Maryland; and Perugia, Italy
Objectives The aim of this study was to define the prevalence and significance of myocardial edema in patients with
non–ST-segment elevation acute coronary syndrome (NSTE-ACS).
Background Most patients with NSTE-ACS undergo angiography, yet not all have obstructive coronary artery disease (CAD)
requiring revascularization. Identifying patients with myocardium at risk could enhance the effectiveness of an
early invasive strategy. Cardiac magnetic resonance (CMR) can demonstrate edematous myocardium subjected
to ischemia but has not been used to evaluate NSTE-ACS patients.
Methods One hundred consecutive patients with NSTE-ACS were prospectively enrolled to undergo 30-min CMR, including
T2-weighted edema imaging and late gadolinium enhancement before coronary angiography. Clinical manage-
ment including revascularization decision-making was performed without CMR results.
Results Of 88 adequate CMR studies, 57 (64.8%) showed myocardial edema. Obstructive CAD requiring revasculariza-
tion was present in 87.7% of edema-positive patients versus 25.8% of edema-negative patients (p  0.001). By
multiple logistic regression analysis after adjusting for late gadolinium enhancement, perfusion, and wall motion
scores, TIMI risk score was not predictive of obstructive CAD. Conversely, an increase in T2 score by 1 U in-
creased the odds of subsequent coronary revascularization by 5.70 times (95% confidence interval: 2.38 to
13.62, p  0.001). Adjusting for peak troponin-I, patients with edema showed a higher hazard of a cardiovascu-
lar event or death within 6 months after NSTE-ACS compared with those without edema (hazard ratio: 4.47,
95% confidence interval: 1.00 to 20.03; p  0.050).
Conclusions In NSTE-ACS patients, rapid CMR identifies reversibly injured myocardium due to obstructive CAD and predicts worse
outcomes. Identifying myocardium at risk may help direct appropriate patients toward early invasive management.
(J Am Coll Cardiol 2010;55:2480–8) © 2010 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2010.01.047r
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mrug therapies and revascularization have greatly reduced
ortality and long-term cardiac impairment for survivors of
cute coronary syndromes (ACS) (1,2). Non–ST-segment
levation acute coronary syndromes (NSTE-ACS) comprise
ver two-thirds of all ACS (3). This group may develop
rreversible myocyte injury, contractile dysfunction, and
rrhythmias; 20% suffer death, myocardial infarction, or
rom the *Ohio State University, Columbus, Ohio; †University of Maryland, College
ark, Maryland; and the ‡University of Perugia, Perugia, Italy. This work was
upported by an Ohio State University DHLRI Research Development Grant,
schemia and Metabolism Thematic Program. Drs. Raman and Simonetti receive
esearch grant support from Siemens.w
Manuscript received August 24, 2009; revised manuscript received November 23,
009, accepted January 2, 2010.ecurrent ischemia by 1 year (3–6). However, predicting
hort-term and long-term risk remains challenging, and
election of initial management strategy varies in this
atient population (7,8).
See page 2489
Variable clinical management including delays in NSTE-
CS care may stem from difficulty in identifying myocar-
ium at risk. Clinical history, electrocardiography (ECG),
nd biomarkers perform well in establishing the diagnosis of
STE-ACS (5); however, they are not designed to detect
yocardium “at risk” but not yet irreversibly injured. Like-
ise, Thrombolysis In Myocardial Infarction (TIMI) (6)
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June 1, 2010:2480–8 CMR in NSTE-ACSnd other global risk scores on the basis of clinical and ECG
ata provide an average estimate of an individual’s risk of
eath or major ischemic events but do not specifically guide
anagement decisions regarding timing of angiography.
ecause myocardium at risk may be salvaged by revascular-
zation, an invasive strategy to identify obstructive coronary
rtery disease (CAD) is usually pursued once ACS is
iagnosed (5). For patients with myocardium at risk, early
ntervention is invaluable (9); however, for patients without
yocardium at risk, a costly invasive strategy confers no
enefit and may add unnecessary bleeding and procedural
isk (4). A diagnostic approach that identifies myocardium
t risk within the heterogeneous NSTE-ACS population
ould facilitate timely revascularization and concentrate
esource use to the most appropriate patients.
Extensive preclinical and human studies have established
hat T2 signal hyperintensity by cardiac magnetic resonance
CMR) indicates increased myocardial water content
10–14). T2 may increase within 30 min of ischemia
nset—before detectable injury by troponin or late gadolin-
um enhancement (LGE) (15,16). T2-weighted CMR to
dentify myocardium that has recently suffered ischemia has
een employed to distinguish ACS from non-ACS and new
rom old infarct scar in patients with undifferentiated chest
ain (14,17–19). We sought to extend this work to inves-
igate whether CMR with edema imaging could stratify
atients admitted with NSTE-ACS to identify higher-risk
atients who would warrant an early invasive management
trategy.
ethods
tudy population. Consecutive patients hospitalized with
STE-ACS awaiting coronary angiography were prospec-
ively enrolled over a 20-month period. Diagnosis required
oth suspected cardiac chest pain or anginal equivalent and
ither abnormal serum troponin-I (TnI) level or ischemic
CG changes (20). Patients under age 30 years were
xcluded to minimize coronary events mediated by nonath-
rosclerotic processes. Contraindication to magnetic reso-
ance such as pacemaker or evidence of illicit drug ingestion
onstituted additional exclusion criteria. Clinical decision-
ardiac Magnetic Resonance Scan ParametersTable 1 Cardiac Magnetic Resonance Scan Parameters
Sequence Type
Parallel
Acceleration
Function Real-time SSFP TSENSE rate 3
Edema T2-weighted triple-inversion STIR segmented
turbo spin echo
GRAPPA rate 2 2
Perfusion Single-shot saturation recovery GRE-EPI TSENSE rate 2
Necrosis Single-shot inversion recovery steady-state
free-precession
GRAPPA rate 2CH  3-chamber; GRAPPA  generalized autocalibrating partially parallel acquisitions; GRE-EPI  gra
teady-state free-precession; STIR  short tau inversion recovery; TR/TE  repetition time/echo time; TSaking was performed by pro-
iders blinded to CMR results.
Medical history, clinical and
CG findings, and serological
arkers were recorded at entry.
ll patients provided written in-
ormed consent to participate in
his Institutional Review Board-
pproved protocol.
MR examination. Examina-
ions were performed with a 1.5-T
MR system and 12-element
hased-array cardiac coil (MAG-
ETOM Avanto, Siemens Med-
cal Solutions, Inc., Erlangen,
ermany). A physician provided
onitoring throughout the study.
he CMR protocol (Table 1) in-
luded 4 acquisition types in the
ollowing order (the first 2 ac-
uired pre-contrast): real-time
ulti-plane cine imaging suitable
or wall motion assessment, T2-weighted imaging, resting
rst-pass perfusion imaging, and LGE. Cine images were
btained in horizontal long-axis (HLA), vertical long-axis
VLA), 3-chamber, and contiguous short-axis (SAX) planes
ith non-breathhold, real-time acquisition (21). T2-weighted
reath-hold (12 to 15 s) turbo spin echo short tau inversion
ecovery images of the myocardium were obtained in 10-mm
asal, mid, and apical SAX, VLA, 3-chamber, and HLA
lanes (12). Myocardial perfusion acquisition used an echo-
lanar first-pass imaging technique in four 10-mm planes:
asal/mid/apical SAX, and HLA (22). Perfusion images were
btained at rest during intravenous infusion of 0.1 mmol/kg
adolinium diethylenetriamine penta-acetic acid. Ten minutes
fter additional 0.1 mmol/kg gadolinium diethylenetriamine
enta-acetic acid administration, multi-plane nonbreathhold
ingle-shot LGE images were obtained in the same planes as
ine imaging, with appropriate inversion time selection to null
ormal myocardium (23).
mage analysis. Two CMR experts (S.V.R., O.P.S.)
linded to clinical information rated by consensus, after
Abbreviations
and Acronyms
CAD  coronary artery
disease
CMR  cardiac magnetic
resonance
ECG  electrocardiography
HLA  horizontal long-axis
IQR  interquartile range
LGE  late gadolinium
enhancement
LV  left ventricular
NSTE-ACS  non–ST-
segment elevation acute
coronary syndrome
SAX  short axis
TIMI  Thrombolysis In
Myocardial Infarction
TnI  troponin-I
VLA  vertical long-axis
Spatial Resolution
Temporal
Resolution (ms) Acquisition Planes
0 3.75 mm  2.1 mm
8-mm slice thickness
62 HLA, VLA, contiguous SAX
(10–12 slices), 3CH
80 1.6 mm  1.6 mm
8-mm slice thickness
156 HLA, VLA, 3 SAX (base,
mid, and apical), 3CH
2 3.1 mm  2.5 mm
10-mm slice thickness
70 3 SAX (base, mid, and
apical), HLA
3 2.8 mm  2.1 mm
8-mm slice thickness
285 HLA, VLA, contiguous SAX
(10–12 slices), 3CHdient-echo, echo-planar hybrid imaging; HLA  horizont
ENSE  Time-adaptive SENSitivity Encoding; VLA  verticTR/TE
(ms)
2.3/1.
 RR/
5.8/1.
2.8/1.al long-axis; SAX  short-axis; SSFP 
al long-axis.
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CMR in NSTE-ACS June 1, 2010:2480–8ndependent review, each patient’s CMR images by
ecording 17-segment (24) scores for each of the follow-
ng: left ventricular (LV) myocardial T2 signal intensity,
all motion, perfusion, and LGE. Each variable was scored:
2: 0-normal, 1-intramyocardial hyperintensity; wall motion:
-normal, 1-hypokinetic, 2-akinetic, 3-dyskinetic; per-
usion: 0-normal, 1-abnormal; and LGE: 0-none,
-hyperenhancement, 2-microvascular obstruction. Con-
ensus scores were obtained for each study by 2 CMR
xperts. Segmental T2, perfusion, wall motion, and LGE
cores were summed to yield patient-level aggregate
cores.
The LV volumes and ejection fraction were estimated
ith the formula: volume  0.85  area^2/length, ml,
nd ejection fraction  (stroke volume)/end-diastolic
olume, % (25).
ubsequent clinical care and outcomes. Invasive coronary
ngiography was done according to standard techniques.
ignificant coronary artery stenosis (70%) was identified
y an independent interventional cardiologist (ELM) by
isual assessment. Subsequent management decisions were
ade by the clinical team on the basis of clinically available
ata, including findings at coronary angiography but with-
ut knowledge of CMR results.
Follow-up at 6 months by phone interview and chart
eview documented the occurrence of death, heart failure,
ajor arrhythmia, or hospital stay for an acute coronary
vent.
tatistical analysis. The mean values of continuous vari-
bles were compared with the 2-sample t test, given the
ormal distribution of the variables, and correlation between
ontinuous variables was computed with the Pearson coef-
cient. Otherwise, comparison of median values was done
ith the 2-sample Wilcoxon rank-sum test. Prevalence
ariables were compared with the 2-sample test for propor-
ion. To test the relationship between presence/absence of
dema and normal/abnormal initial TnI, a tetrachoric cor-
elation coefficient was calculated. Logistic regression was
Baseline Characteristics of Study PopulationTable 2 Baseline Characteristics of Study P
All Patients
(n  88)
Age, yrs 59.1 12.1
Male 57 (64.8)
Body mass index, kg/m2 29.4 (25.8–33.1)
Diabetes 38 (43.2)
Smoker 45 (51.1)
Hypertension 69 (78.4)
Prior CAD 47 (53.4)
Initial troponin-I, mg/dl 0.11 (0.01–0.99)
Peak troponin-I, mg/dl 8.2 16.2
TIMI risk score 4 (3–5)Values are mean  SD, n (%), or median (interquartile range). *p  0.05 con
CAD  coronary artery disease; IQR  interquartile range; TIMI  Thrombosed to model the relationship between edema-positivity
nd peak TnI as well as LGE score. Logistic regression of
ntervention on T2 score was performed by adjusting for
GE score, wall motion score, and myocardial perfusion
core. Cox proportional hazards regression model was used
o evaluate the composite occurrence of events within
-month follow-up with a group predictor on the basis of
resence/absence of edema.
esults
tudy population. Six patients screened were not enrolled
ue to respiratory or hemodynamic instability (n  5) or
entricular tachyarrhythmia (n  1). Of 100 patients
nrolled, 5 could not complete CMR examination due to
laustrophobia; T2 image quality was inadequate in 7
atients. Patient characteristics for the remaining study
opulation (n  88) are summarized in Table 2; all were in
inus rhythm at the time of CMR examination.
Subject race was African-American in 11 (13%) and
aucasian in the remainder. The majority of patients were
verweight (median body mass index 30.1 kg/m2, interquar-
ile range [IQR] 25.8 to 33.0 kg/m2). Thirty-three (38%)
atients in this study group were transferred to our institu-
ion after initial presentation to another hospital. Peak TnI
or patients who were troponin-positive (n  77) occurred
t admission in 9 (12%), after admission but before cathe-
erization in 49 (64%), and after catheterization in 19 (25%).
MR findings. Global LV systolic function was preserved
n this population: ejection fraction averaged 61  14%.
edian wall motion score was 4 (IQR 1 to 10), with 80%
f patients having at least 1 dysfunctional LV segment.
edian perfusion score was 1 (IQR 0 to 3). Similarly,
edian LGE score was 1 (IQR 0 to 3); LGE score was
on-zero in 53 patients (60.2%). As expected, LGE score
ncreased with increasing peak TnI (R  0.28, p  0.05).
T2-weighted and LGE imaging allowed assessment of
resence and extent of myocardial edema and irreversible
njury (Fig. 1). Edema was detected in 57 patients (64.8%),
tion
ts Managed
edically
n  30)
Patients Receiving
Revascularization
(n  58) p Value
.6 11.3 59.4 12.5 0.78
(53.3) 41 (69.4) 0.11
(23.4–31.8) 30.2 (27.4–34.2) 0.02*
(40.0) 26 (44.8) 0.66
(40.0) 33 (56.9) 0.13
(86.7) 43 (74.1) 0.18
(60.0) 29 (50.0) 0.37
(0.01–0.30) 0.14 (0.02–1.13) 0.17
.3 14.7 7.9 18.9 0.89
(3–5) 4.5 (3–5) 0.47opula
Patien
M
(
58
16
27.5
12
12
26
18
0.05
8
4sidered significant.
lysis In Myocardial Infarction.
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June 1, 2010:2480–8 CMR in NSTE-ACSith a median of 2 (IQR 0 to 3) segments per patient
howing edema. Clinical characteristics, including TIMI
isk score, were similar between patients with versus those
ithout edema (Table 3). Time from initial admission to
MR was also similar in patients with versus those without
dema (45.9  36.1 h vs. 53.9  52.3 h, p  0.45). There
as greater prevalence of myocardial edema in patients
ransferred in from an outside hospital versus patients
resenting directly to Ohio State University (41 of 55 or
4% vs. 16 of 33 or 48%, p  0.01).
Figure 1 Myocardial Edema at Initial Presentation With NSTE-A
Magnetic resonance images obtained in a 63-year-old female nonsmoker with che
from 0.04 to 2.36 mg/dl over the initial hours of hospital stay. T2-weighted imagin
gadolinium enhancement (B) indicates irreversible injury. There is corresponding w
compared with end-diastole (D) of a vertical long-axis cine. NSTE-ACS  non–ST-se
atient Characteristics byyocardial Edema on T2-Weighted ImagingTable 3 Pa ient Characteristics byMyocardial Edema on T2-Weighted Imaging
Edema Absent
(n  31)
Edema Present
(n  57) p Value
Age, yrs 58.2 10.3 59.6 13.0 0.59
Male 18 (58.1) 39 (68.4) 0.33
Body mass index, kg/m2 29.3 (24.5–32.8) 29.5 (27.2–33.1) 0.86
Diabetes 12 (38.7) 26 (45.6) 0.53
Smoker 12 (38.7) 33 (57.9) 0.20
Hypertension 27 (87.1) 42 (73.7) 0.14
TIMI risk score 4 (3–5) 4 (3–5) 0.59
History of CAD 18 (58.1) 29 (50.9) 0.52
Baseline ECG, ST-segment
depression
13 (41.9) 28 (49.1) 0.52
Peak troponin-I, mg/dl 0.43 (0.05–1.48) 4.66 (0.92–12.65) 0.01i
alues are mean  SD, n (%), or median (interquartile range). *p  0.05 considered significant.
ECG  electrocardiography; other abbreviations as in Table 2.Patients with edema were more likely to have evidence of
yocardial injury. Median LGE score was 2 (IQR 0 to 4) in
he T2-positive compared with 0 (IQR 0 to 2) in T2-
egative patients (p  0.01). Similarly, patients with edema
lso had higher peak TnI values by the end of their hospital
tay compared with patients without myocardial edema:
1.15  18.4 mg/dl versus 2.72  8.98 mg/dl, respectively
p  0.05).
Initial TnI positivity was not significantly related to
dema positivity (tetrachoric correlation coefficient  0.31);
hat is, patients with negative initial TnI could have edema.
ndeed, among 34 patients with negative initial TnI, 18
atients were T2-positive; of note, subsequent TnI elevation
eveloped in 17 of 18 patients. We also identified patients
ith areas of edema in the absence of gross irreversible
njury by LGE: of 34 LGE-negative patients, 17 (48.6%)
howed edema on T2-weighted imaging (Fig. 2). Initial
nI values did not discriminate within this LGE-negative
ubgroup (0.37  0.45 mg/dl if edema-positive vs. 0.28 
.47 mg/dl if edema-negative, p  0.57). Twenty-eight
atients demonstrated an area subtended by edema that was
arger than that showing irreversible injury by an average of
.5 LV segments, consistent with edema as marker of
rea-at-risk.
ngiographic findings. Adding a 30-min CMR proto-
ol to the patients’ initial evaluation process did not
, nonspecific electrocardiographic abnormalities, and troponin-I that increased
vertical long-axis plane) shows infero-apical edema (arrow), and late post-
tion abnormality indicated by abnormal myocardial thickening at end-systole (C)
t elevation acute coronary syndrome.CS
st pain
g (A;
all mo
gmenmpact timing of usual care, with median door-to-
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CMR in NSTE-ACS June 1, 2010:2480–8atheterization time of 37 (IQR 22 to 63) h. Identifica-
ion of 70% stenosis by angiography resulted in percu-
aneous coronary intervention alone in 45 patients,
oronary artery bypass graft surgery alone in 10, and both
ercutaneous coronary intervention and coronary artery
ypass graft surgery in 3 for a total of 58 (66%) patients
eing revascularized versus 30 (34%) without significant
oronary stenosis treated with medical management
lone.
Clinical and functional variables were largely nondis-
riminating between patients with versus those without
AD requiring revascularization (Table 2). Median
IMI risk score was 4.5 in patients who were revascu-
arized and 4.0 in those treated medically (p  0.47). In
ontrast, presence of edema was an extremely powerful
iscriminator: 50 of 57 (87.7%) patients showing T2-
ositivity had obstructive CAD requiring revasculariza-
ion, compared with 8 of 31 (25.8%) T2-negative patients
p  0.001) (Fig. 3). After controlling for LGE score,
erfusion score, and wall motion score, TIMI risk score
as not predictive, whereas T2 score was predictive of
bstructive CAD requiring revascularization; an increase
n T2 score by 1 U increased the odds of revascularization
y 5.70 times (95% confidence interval: 2.38 to 13.62,
Figure 2 Myocardial Edema Without Necrosis in Unstable Angi
Magnetic resonance images were obtained in a 41-year-old male smoker with non
including troponin-I and creatine kinase-myocardial band. T2-weighted imaging (A;
inferoseptum from base to apex. Edema was present without infarction, on the ba
to-noise in the edematous versus remote myocardial regions averaged 18.8  5.1
subendocardial abnormality (C, arrow). End-diastolic (D) and end-systolic (E) frames f
pared with the lateral wall. Overall left ventricular (LV) ejection fraction was 40%. Invas
supplying an occluded left anterior descending coronary artery, prompting surgical reva 0.001).There were 8 instances where CMR showed no edema,
ut revascularization was performed. In 2, other CMR
ndings indicated significant coronary artery stenosis—1
atient had dense segmental wall motion abnormalities, and
he second had segmental wall motion and corresponding
ense perfusion abnormalities. In the remaining 6, anatomic
tenosis by angiography that prompted revascularization
roduced no corresponding abnormality in any CMR mea-
gment elevation acute coronary syndrome and serially negative biomarkers
tal long-axis and serial short axis planes) showed edema (arrows) involving the
lack of late gadolinium enhancement at the same slice locations (B). Contrast-
istent with prior reports using this technique. Resting perfusion showed a mild
horizontal long-axis cine showed abnormal thickening of the septum (E, arrow) com-
giography (F) confirmed high-grade right coronary artery (RCA) stenosis (F, arrow)
ization.
Figure 3 Edema at NSTE-ACS Presentation
Portends Need for Coronary Revascularization
Presence of 70% coronary stenosis requiring revascularization was consider-
ably higher in non–ST-segment elevation acute coronary syndrome (NSTE-ACS)
patients with myocardial edema by magnetic resonance imaging compared with
those without edema.na
–ST-se
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June 1, 2010:2480–8 CMR in NSTE-ACSure (i.e., wall motion, perfusion, T2 imaging, and LGE
ere all normal). Further evaluation of coronary lesion
ignificance with techniques such as fractional flow reserve
as not done.
In 7 instances, CMR showed edema, but coronary
evascularization was not performed. All 7 patients had
ignificant coronary atherosclerosis; however, 3 had no
echnically suitable anatomic targets for revascularization. A
ourth had angiographic findings suggestive of plaque that
ikely produced distal embolization and myocardial sequelae
ithout residual stenosis.
linical outcomes. Five patients had disconnected phone
umbers without recurrent hospital stays at our institution
r the facility where they had initially presented. In the
emaining patients, 16 events occurred during the 6 months
fter initial NSTE-ACS admission: 12 (14%) had recurrent
STE-ACS (7 unstable angina, 5 subendocardial MI)
equiring hospital stay, 2 (2%) were hospitalized for heart
ailure, and 2 died during the follow-up period—1 due to
resumed cardiac arrest at home, and another due to
rogressive renal failure in the setting of multiple myeloma;
f note, all but 2 events occurred in edema-positive patients
Fig. 4).
Figure 5 shows the Kaplan-Meier survival function esti-
ates in patients by edema status. Applying Cox modeling
fter adjusting for peak troponin-I demonstrated that,
egardless of revascularization, patients with edema showed
higher hazard of a cardiovascular event or death within 6
onths after NSTE-ACS compared with those without
dema (hazard ratio: 4.47, 95% confidence interval: 1.00 to
Figure 4 Distribution of Patients by Edema and Revascularizati
Shaded circles indicate adverse events at 60-day follow-up; all but 2 occurred in the non–0.03; p  0.050).iscussion
n this prospective study of patients with NSTE-ACS
ndergoing invasive coronary angiography, myocardial
dema identified by rapid CMR examination distinguished
atients with significant CAD requiring coronary revascu-
arization. In contrast, clinical variables that included TIMI
isk score, cardiac enzyme levels, and ECG changes—all of
atus
ent elevation acute coronary syndrome patients who were edema-positive at baseline.
Figure 5 Kaplan-Meier Survival Function
Estimates in Patients by Edema Status
Estimated survival functions for the time to major adverse cardiac event or
death in non–ST-segment elevation acute coronary syndrome patients indicates
a greater cumulative hazard of subsequent events in patients with edema at
presentation compared with those without edema.on St
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CMR in NSTE-ACS June 1, 2010:2480–8hich are nonetheless essential to diagnose NSTE-ACS—
id not discriminate among patients with established
STE-ACS as to who would go on to require subsequent
evascularization after coronary angiography versus those
hat would be treated with medical management alone.
Our findings indicate that demonstrating myocardial
dema in vivo in patients with NSTE-ACS can be a
owerful tool with major clinical implications. It has long
een known that myocardial ischemia of sufficient duration
eaves behind an area of edema (26,27) that can be visual-
zed by CMR (14,28,29). This can establish the occurrence
f ischemic episodes in patients presenting with undiffer-
ntiated chest pain (14,17). However, in this work we did
ot exploit T2-positivity to reveal a “history” of recent
yocardial ischemia, because our study enrolled patients in
hom the diagnosis of NSTE-ACS was already established.
nstead, we used edema imaging to identify myocardium
ot irreversibly injured but at risk of further injury and
ence most likely to benefit from an early invasive strategy.
urthermore, we found a sizable number of patients with
STE-ACS with only T2-positivity, negative initial
roponin-I, and no LGE, consistent with areas of myocar-
ium where transient flow reduction with sufficient duration
r severity has produced edema without irreversible injury.
he implication in NSTE-ACS is that visualization of
dematous but not-yet-irreversibly injured myocardium sig-
als the presence of a coronary artery lesion susceptible to
epeated episodes of transient coronary artery thrombus
ormation, which requires aggressive treatment to minimize
rreversible injury.
Review of revascularization strategy used in our series of
atients showed consistency with American Heart Associ-
tion/American College of Cardiology guidelines that ad-
ocate percutaneous coronary intervention or coronary ar-
ery bypass graft surgery for NSTE-ACS patients identified
ith significant coronary artery stenosis (5); type of revas-
ularization strategy was not distinguished in our study.
ecause of the reliance on coronary anatomic findings and
urrent practice that emphasizes an early invasive strategy in
anagement of NSTE-ACS, we maintained this paradigm
n our study by adding CMR with T2-weighted imaging of
dema in all subjects without affecting time to angiography.
ur finding of the ability of CMR to predict flow-limiting
AD suggests that edema imaging may, by demonstrating
yocardium in jeopardy, demonstrate a myocardial signa-
ure of diverse pathophysiological processes and clinical
vents with relevance to management. Although our study
as not powered to assess outcomes, we identified a trend to
orse prognosis in edema-positive patients that was present
espite the presumed benefits of greater frequency of
evascularization in this cohort.
tudy limitations. We did not enroll low-risk patients
ithout a definite plan to pursue invasive coronary angiog-
aphy. This population represents a subset of all NSTE-
CS patients where the risk/benefit profile of an earlynvasive strategy is less certain. Lack of randomization is pnother limitation of our study, as is the relatively small
umber of outcome events limiting the ability to define the
nique prognostic utility of identifying edema. Given the
romising results of this work, a prospective randomized
rial to assess the merits of CMR in guiding therapeutic
trategy in this population is warranted.
Limitations of the short-TI inversion recovery technique
or T2-weighted myocardial imaging include sensitivity to
otion that may result in the false appearance of relative
ignal enhancement. Although we used the surface coil
ormalization algorithm provided by the vendor, we recog-
ize use of a surface coil for T2-weighted imaging as a
imitation. Quantitative T2-mapping should offer a more
obust method of identifying regional myocardial edema,
ompared with visual assessment of T2-weighted images
30).
linical implications. Potential discrepancies between
MR-derived myocardium at risk and angiography illumi-
ate distinctions between the information provided by the 2
odalities. In patients without edema who were felt to
equire coronary revascularization after angiography, most
ctually had no CMR abnormalities by cine, perfusion, or
GE imaging, that is, anatomic disease without myocardial
equelae. The long-term benefit of revascularization in such
ases remains uncertain, particularly in light of recent
tudies that suggest inconsistent improvement in outcomes
hen adjusting for treatment selection bias (31,32). Con-
ersely, CMR findings of edema without subsequent revas-
ularization need not indicate “false-positives.” Our results
ndicated a substantial coronary atherosclerosis burden in all
uch patients, albeit without suitable anatomic targets for
evascularization and possible resolution of thrombus before
MR because of intensive anticoagulant therapy.
In this prospective study, we did not randomize patients
o early invasive versus selectively invasive strategy on the
asis of CMR findings, nor were patients’ revascularization
r other management decisions affected by CMR results.
urther randomized studies are warranted to study the
mpact of CMR with edema imaging on selection of
anagement strategies in patients with NSTE-ACS to
dentify approaches that reduce adverse events (20,32–35).
f such studies confirm the predictive value suggested by our
ork, CMR at regional medical centers could help distin-
uish patients who would benefit from accelerated transfer
o facilities with interventional capabilities from those in
hom invasive angiography is not likely to identify need for
evascularization. Cost-effectiveness analyses are also re-
uired to evaluate adding CMR into the initial evaluation of
STE-ACS versus current practice, which in many centers
outinely deploys even costlier invasive angiography in these
atients (36).
onclusions
apid CMR examination including imaging of edema,
erfusion, wall motion, and irreversible injury identifies
m
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June 1, 2010:2480–8 CMR in NSTE-ACSyocardium at risk in NSTE-ACS patients. This diagnos-
ic strategy does not require stress, and may define a
yocardial signature predictive of obstructive CAD requir-
ng revascularization. Use of rapid CMR upon admission
or NSTE-ACS warrants further evaluation through ran-
omized trials as a tool to optimize selection of an early
nvasive strategy in these patients.
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